Altimmune, Inc. (ALT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 519.71M |
| Enterprise Value | 338.24M |
| Trailing P/E | 1.82 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.04k |
| Price/Book (mrq) | 3.01 |
| Enterprise Value/Revenue | 824.98 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.20 |
| 52-Week Change 3 | 83.25% |
| S&P500 52-Week Change 3 | 26.14% |
| 52 Week High 3 | 14.84 |
| 52 Week Low 3 | 2.09 |
| 50-Day Moving Average 3 | 8.06 |
| 200-Day Moving Average 3 | 6.45 |
Share Statistics
| Avg Vol (3 month) 3 | 4.25M |
| Avg Vol (10 day) 3 | 2.82M |
| Shares Outstanding 5 | 70.9M |
| Implied Shares Outstanding 6 | 71.48M |
| Float 8 | 70.34M |
| % Held by Insiders 1 | 0.78% |
| % Held by Institutions 1 | 63.34% |
| Shares Short (Apr 30, 2024) 4 | 22.31M |
| Short Ratio (Apr 30, 2024) 4 | 7.15 |
| Short % of Float (Apr 30, 2024) 4 | 31.71% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 31.46% |
| Shares Short (prior month Mar 28, 2024) 4 | 17.73M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Sept 14, 2018 |
| Ex-Dividend Date 4 | Jan 20, 2017 |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Sept 14, 2018 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -535,879.98% |
Management Effectiveness
| Return on Assets (ttm) | -29.48% |
| Return on Equity (ttm) | -54.46% |
Income Statement
| Revenue (ttm) | 410k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | -76.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -88.09M |
| Net Income Avi to Common (ttm) | -92.77M |
| Diluted EPS (ttm) | -1.60 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 182.02M |
| Total Cash Per Share (mrq) | 2.57 |
| Total Debt (mrq) | 552k |
| Total Debt/Equity (mrq) | 0.32% |
| Current Ratio (mrq) | 16.55 |
| Book Value Per Share (mrq) | 2.44 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -72.76M |
| Levered Free Cash Flow (ttm) | -45.06M |
© 2024 Yahoo. All rights reserved.